Oslo
Norway
4
2013-08-01
3
2014-12-16
These are the the leading inventors for applications assigned to CLAVIS PHARMA ASA:
CLAVIS PHARMA ASA based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Parenteral formulations of elacytarabine derivatives
#2 | 2013-01-03Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate
#3 | 2010-04-22 ✅ Patent 9,428,540 granted on 2016-08-30Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
#4 | 2009-08-20 ✅ Patent 8,399,420 granted on 2013-03-19Azacytidine analogues and uses thereof
1907 ⎘